Reaching the Threshold: A Multilayer Pathogenesis of Macrophage Activation Syndrome

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Rheumatology

• Publication date

  2013-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3899/jrheum.121233PMID 23588947
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

  2012cited by this paper
• Critical role for perforin and Fas-dependent killing of dendritic cells in the control of inflammation.

  2012cited by this paper
• Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment

  2012cited by this paper
• Amplification of the response to Toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: implication for the pathogenesis of macrophage activation syndrome.

  2012cited by this paper
• Hemophagocytic lymphohistiocytosis: updates and evolving concepts

  2012cited by this paper
• Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice.

  2011cited by this paper
• Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice

  2011cited by this paper
• Association of IRF5 Polymorphisms with Susceptibility to Macrophage Activation Syndrome in Patients with Juvenile Idiopathic Arthritis

  2011cited by this paper
• Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.

  2011cited by this paper
• Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome.

  2011cited by this paper
• A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice.

  2011cited by this paper
• Monitoring serum IL-18 levels is useful for treatment of a patient with systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome

  2011cited by this paper
• Perforin is a critical physiologic regulator of T-cell activation.

  2011cited by this paper
• Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients.

  2011cited by this paper
• Hemophagocytosis causes a consumptive anemia of inflammation

  2011cited by this paper
• Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.

  2011cited by this paper
• Cytokine Profiles of Macrophage Activation Syndrome Associated with Rheumatic Diseases

  2010cited by this paper
• Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis.

  2010cited by this paper
• Chronic Murine Typhoid Fever Is a Natural Model of Secondary Hemophagocytic Lymphohistiocytosis

  2010cited by this paper
• Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis.

  2010cited by this paper
• Review of haemophagocytic lymphohistiocytosis

  2010cited by this paper
• Macrophage activation syndrome: advances towards understanding pathogenesis

  2010cited by this paper
• IL‐1: Discoveries, controversies and future directions

  2010cited by this paper
• Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis.

  2009cited by this paper
• Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis.

  2009cited by this paper
• Neutralization of IFNγ defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice

  2009cited by this paper
• Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis

  2008cited by this paper
• Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms.

  2008cited by this paper
• Macrophage activation and polarization.

  2008cited by this paper
• Early diagnostic and prognostic significance of a specific Th1/Th2 cytokine pattern in children with haemophagocytic syndrome

  2008cited by this paper
• Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell?

  2008cited by this paper
• HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

  2007cited by this paper
• Macrophage activation syndrome.

  2006cited by this paper
• Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo.

  2006cited by this paper
• Perforin and granzymes have distinct roles in defensive immunity and immunopathology.

  2006cited by this paper
• Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome.

  2005cited by this paper
• Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages.

  2005cited by this paper
• Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

  2005cited by this paper
• Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome

  2004cited by this paper
• Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

  2004cited by this paper
• An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.

  2004cited by this paper
• Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome.

  2003cited by this paper
• Macrophage activation syndrome.

  2002cited by this paper
• Impaired NK Cell Development in an IFN-γ Transgenic Mouse: Aberrantly Expressed IFN-γ Enhances Hematopoietic Stem Cell Apoptosis and Affects NK Cell Differentiation1

  2002cited by this paper
• Impaired NK cell development in an IFN-gamma transgenic mouse: aberrantly expressed IFN-gamma enhances hematopoietic stem cell apoptosis and affects NK cell differentiation.

  2002cited by this paper
• A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases.

  2001cited by this paper
• The Production of IFN-γ by IL-12/IL-18-Activated Macrophages Requires STAT4 Signaling and Is Inhibited by IL-41

  2001cited by this paper
• Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis.

  1991cited by this paper
• IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA.

  1990cited by this paper
• Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF.

  1990cited by this paper
• IL-1 stimulates IL-6 production in endothelial cells.

  1989cited by this paper
• Extended Report

  year unknowncited by this paper

• Coagulation dysfunction in children with secondary hemophagocytic lymphohistiocytosis: a comprehensive analysis

  2026cites this paper
• Beyond genotype: challenges in predicting disease risk for carriers of biallelic perforin variants

  2025cites this paper
• Macrophage Activation Syndrome in Kawasaki Disease: Insights from a Systematic Literature Review on Diagnosis, Clinical Features, and Treatment

  2025cites this paper
• Genetic challenges in the hole puncher.

  2025cites this paper
• Hemophagocytic Lymphohistiocytosis Gene Variants in Severe COVID-19 Cytokine Storm Syndrome

  2025cites this paper
• Case Report: Late-onset primary hemophagocytic lymphohistiocytosis leading to the diagnosis of Griscelli syndrome type 2 in a young woman with phenotypically inapparent partial albinism

  2025cites this paper
• Macrophage activation syndrome in Sepsis: from pathogenesis to clinical management

  2024cites this paper
• Cytokines in Cytokine Storm Syndrome.

  2024cites this paper
• Role of DOCK8 in Cytokine Storm Syndromes.

  2024cites this paper
• Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis.

  2024cites this paper
• Macrophage Activation Syndrome in Children: Update on Diagnosis and Treatment

  2024cites this paper
• Macrophage Activation Syndrome Presents as Initial Manifestation of Lupus in an Adult Female

  2024cites this paper
• New discoveries in the genetics and genomics of systemic juvenile idiopathic arthritis

  2024cites this paper
• Clinical features of macrophage activation syndrome in adult dermatomyositis: A single‐center retrospective case‐control study

  2024cites this paper
• Severe adult haemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants.

  2023cites this paper
• Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19

  2023cites this paper
• The Multifaceted Immunology of Cytokine Storm Syndrome.

  2023cites this paper
• DOCK2 Mutation and Recurrent Hemophagocytic Lymphohistiocytosis

  2023cites this paper
• Kikuchi‐Fujimoto disease complicated with hemophagocytic lymphohistiocytosis

  2023cites this paper
• The Role of Immune Mechanisms, Inflammatory Pathways, and Macrophage Activation Syndrome in the Pathogenesis of Hemophagocytic Lymphohistiocytosis

  2022cites this paper
• Risk factors of early death in pediatric hemophagocytic lymphohistocytosis: Retrospective cohort study

  2022cites this paper
• Cytokine Storm Syndrome.

  2022cites this paper
• Case report and literature review: Hemophagocytic lymphohistiocytosis in a pregnant woman with systemic lupus erythematosus with Syntaxin 11 gene defect

  2022cites this paper
• Biologic disease-modifying antirheumatic drugs to treat multisystem inflammatory syndrome in children

  2022cites this paper
• Hemophagocytic Lymphohistiocytosis Gene Variants in Multisystem Inflammatory Syndrome in Children

  2022cites this paper
• Role of Distinct Macrophage Populations in the Development of Heart Failure in Macrophage Activation Syndrome

  2022cites this paper
• A Rare STXBP2 Mutation in Severe COVID-19 and Secondary Cytokine Storm Syndrome

  2022cites this paper
• Exploring Macrophage Activation Syndrome Secondary to Systemic Lupus Erythematosus in Adults: A Systematic Review of the Literature

  2021cites this paper
• The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?

  2021cites this paper
• Macrophage activation syndrome in a patient with adult-onset Still’s disease following first COVID-19 vaccination with BNT162b2

  2021cites this paper
• Macrophage Activation Syndrome in Children: Diagnosis and Management

  2021cites this paper
• Macrophage activation syndrome in a newborn: report of a case associated with neonatal lupus erythematosus and a summary of the literature

  2021cites this paper
• Macrophage Polarization and Plasticity in Systemic Lupus Erythematosus

  2021cites this paper
• Macrophage Activation Syndrome in Childhood Inflammatory Disorders: Diagnosis, Genetics, Pathophysiology, and Treatment

  2020cites this paper
• Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis

  2020cites this paper
• Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome

  2020cites this paper
• The genetics of macrophage activation syndrome

  2020cites this paper
• Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches

  2020cites this paper
• Anotaciones breves sobre el síndrome de liberación de citocinas y el bloqueo terapéutico de la interleucina-6 en SARS-CoV-2/COVID-19

  2020cites this paper
• Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic

  2020cites this paper
• Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations

  2020cites this paper
• Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019

  2020cites this paper
• Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management

  2019cites this paper
• Hemophagocytic Lymphohistiocytosis ： A Skeleton in the Cupboard of Adult Idiopathic Inflammatory Myopathies.

  2019cites this paper
• Haploinsufficiency of UNC13D increases the risk of lymphoma

  2019cites this paper
• Posttransplant Hemophagocytic Lymphohistiocytosis Driven by Myeloid Cytokines and Vicious Cycles of T-Cell and Macrophage Activation in Humanized Mice

  2019cites this paper
• The Immunology of Macrophage Activation Syndrome

  2019cites this paper
• Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment

  2019cites this paper
• Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg.

  2019cites this paper
• acrophage Activation Syndrome as the Initial Manifestation of Severe Juvenile nset Systemic Lupus Erythematosus . Favorable Response o Cyclophosphamide

  2018cites this paper
• Convergent pathways of the hyperferritinemic syndromes

  2018cites this paper
• H‐ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome

  2018cites this paper
• Brief Report: Novel UNC13D Intronic Variant Disrupting an NF‐κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis

  2018cites this paper
• Lymphocyte‐independent pathways underlie the pathogenesis of murine cytomegalovirus‐associated secondary haemophagocytic lymphohistiocytosis

  2018cites this paper
• Adults with septic shock and extreme hyperferritinemia exhibit pathogenic immune variation

  2018cites this paper
• Macrophage Activation Syndrome: different mechanisms leading to a one clinical syndrome

  2017cites this paper
• Neutralization of IFN‐&ggr; reverts clinical and laboratory features in a mouse model of macrophage activation syndrome

  2017cites this paper
• Title Page Title: H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome Short title: H-ferritin in MAS

  2017cites this paper
• Systemic juvenile idiopathic arthritis: New insights into pathogenesis and cytokine directed therapies.

  2017cites this paper
• Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

  2016cites this paper
• Genetic predisposition to hemophagocytic lymphohistiocytosis: Report on 500 patients from the Italian registry

  2016cites this paper
• Development of spondyloarthropathy following episodes of macrophage activation syndrome in children with heterozygous mutations in haemophagocytic lymphohistiocytosis-associated genes.

  2016cites this paper
• The influence of various therapeutic regimens on early clinical and laboratory response and outcome of children with secondary hemophagocytic lymphohistiocytosis

  2016cites this paper
• Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities

  2016cites this paper
• 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

  2016cites this paper
• Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus

  2016influential citation
• Macrophage Activation Syndrome.

  2015cites this paper
• Inhibition of Natural Killer Cell Cytotoxicity by Interleukin‐6: Implications for the Pathogenesis of Macrophage Activation Syndrome

  2015cites this paper
• Hemophagocytic lymphohistiocytosis (HLH): A heterogeneous spectrum of cytokine-driven immune disorders.

  2015cites this paper
• Updates on histiocytic disorders

  2014cites this paper
• MEETING REPORT Updates on Histiocytic Disorders

  2014cites this paper
• Síndrome de activación de macrófago como manifestación inicial de lupus eritematoso sistémico severo de inicio juvenil. Respuesta favorable a ciclofosfamida

  2014cites this paper
• Macrophage activation syndrome as the initial manifestation of severe juvenile onset systemic lupus erythematosus. Favorable response to cyclophosphamide.

  2014cites this paper
• Tocilizumab for systemic juvenile idiopathic arthritis.

  2013cites this paper